An unconventional new model makes industry meetups a key part of medical device regulation.
With tests in short supply, some hospitals are creating homegrown versions in their own labs. The pandemic may prove how essential such efforts are.
Prolapse of the pelvic organs is uncomfortable and widespread, and its treatments are sometimes dangerous. But new approaches are on the way.
Fecal microbiota transplants run into a semantic crisis.
What if drugs were released to the public earlier, then graded on their performance in the real world?
When patients demand more than science can provide, high-priced, ineffective treatments can reach the market.
A new technology quickly spreads genetic mutations in the wild. Who will keep it from getting out of hand?
The most damaging forms of multiple sclerosis get new treatments, including one that is already widely available.
A new vaccine may prevent valley fever and break a long-standing impasse on fungal research.
The Food and Drug Administration tries a fresh approach to medical devices suspected of falling short.